Report Library
View More
Non-Small Cell Lung Cancer (NSCLC) ...
May 9, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 7, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 6, 2024
Renal Cell Carcinoma (RCC) KOL Inte...
May 3, 2024
Melanoma KOL Interview - US, Midwes...
April 30, 2024
Datamonitor Healthcare Infectious D...
April 29, 2024
Datamonitor Healthcare CV&Met Disea...
April 29, 2024
Datamonitor Healthcare I&I: Axial S...
April 29, 2024
Datamonitor Healthcare Infectious D...
April 29, 2024
Melanoma KOL Interview - Germany
April 26, 2024
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/20/24 | Esperion Therapeutics (ESPR) | Nexletol for Dyslipidemia / Hypercholesterolemia | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/19/24 | Chiesi Farmaceutici | GB002 for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/17/24 | Viatris (VTRS) | Pretomanid for Tuberculosis | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/16/24 | Eli Lilly (LLY) | Efsitora alfa for Diabetes Mellitus, Type II | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/13/24 | Novo Nordisk (NVO) | Mim8 for Hemophilia A | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/19/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 04/09/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 04/18/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |